Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Lynette Siv Chea & Rama Rao Amara. (2017) Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models. Expert Review of Vaccines 16:10, pages 973-985.
Read now
Read now
James I Dunlop, Anna M Owsianka, Vanessa M Cowton & Arvind H Patel. (2015) Current and future prophylactic vaccines for hepatitis C virus. Vaccine: Development and Therapy 5, pages 31-44.
Read now
Read now
Alberto Fernández-Tejada, Barton F Haynes & Samuel J Danishefsky. (2015) Designing synthetic vaccines for HIV. Expert Review of Vaccines 14:6, pages 815-831.
Read now
Read now
Derrick Louz, Hans E. Bergmans, Birgit P. Loos & Rob C. Hoeben. (2013) Animal models in virus research: their utility and limitations. Critical Reviews in Microbiology 39:4, pages 325-361.
Read now
Read now
Sorachai Nitayaphan, Viseth Ngauy, Robert O’Connell & Jean-Louis Excler. (2012) HIV epidemic in Asia: optimizing and expanding vaccine development. Expert Review of Vaccines 11:7, pages 805-819.
Read now
Read now
Articles from other publishers (36)
John T. Schiller, Lauri E. Markowitz, Aimée R. Kreimer & Douglas R. Lowy. 2023. Plotkin's Vaccines. Plotkin's Vaccines
484
513.e11
.
Edith A. M. Tarimo, Joel Ambikile, Patricia Munseri & Muhammad Bakari. (2022) Personal experiences following acquiring HIV infection while volunteering in Phase I/II HIV vaccine trials: A qualitative study from Tanzania. PLOS ONE 17:10, pages e0276404.
Crossref
Crossref
Yi Liu, Kai Wang, Tarik F. Massoud & Ramasamy Paulmurugan. (2020) SARS-CoV-2 Vaccine Development: An Overview and Perspectives. ACS Pharmacology & Translational Science 3:5, pages 844-858.
Crossref
Crossref
E.N. Gary, N. Kathuria, G. Makurumidze, A. Curatola, A. Ramamurthi, M.E. Bernui, D. Myles, J. Yan, P. Pankhong, K. Muthumani, E. Haddad, L. Humeau, D.B. Weiner & M.A. Kutzler. (2020) CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine. Vaccine 38:11, pages 2626-2635.
Crossref
Crossref
Christopher Kwesi O. WilliamsChristopher Kwesi O. Williams. 2019. Cancer and AIDS. Cancer and AIDS
3
63
.
Kathryn Therese Mngadi, Bhavna Maharaj, Yajna Duki, Douglas Grove & Jessica Andriesen. (2018) Using Mobile Technology (pMOTAR) to Assess Reactogenicity: Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols 7:10, pages e175.
Crossref
Crossref
Hongzhao Li, Yan Hai, So-Yon Lim, Nikki Toledo, Jose Crecente-Campo, Dane Schalk, Lin Li, Robert W. Omange, Tamara G. Dacoba, Lewis R. Liu, Mohammad Abul Kashem, Yanmin Wan, Binhua Liang, Qingsheng Li, Eva Rakasz, Nancy Schultz-Darken, Maria J. Alonso, Francis A. Plummer, James B. Whitney & Ma Luo. (2018) Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques. PLOS ONE 13:8, pages e0202997.
Crossref
Crossref
Xianliang Sun, Han Zhang, Shuiling Xu, Lili Shi, Jingjian Dong, Dandan Gao, Yan Chen & Hao Feng. (2017) Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses. Virology Journal 14:1.
Crossref
Crossref
C. Yong Kang & Yong Gao. (2017) Killed whole-HIV vaccine; employing a well established strategy for antiviral vaccines. AIDS Research and Therapy 14:1.
Crossref
Crossref
Eunsil Choi, Chad J. Michalski, Seung Ho Choo, Gyoung Nyoun Kim, Elizabeth Banasikowska, Sangkyun Lee, Kunyu Wu, Hwa-Yong An, Anthony Mills, Stefan Schneider, U. Fritz Bredeek, Daniel R. Coulston, Shilei Ding, Andrés Finzi, Meijuan Tian, Katja Klein, Eric J. Arts, Jamie F. S. Mann, Yong Gao & C. Yong Kang. (2016) First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses. Retrovirology 13:1.
Crossref
Crossref
David H. Jolly, Monique P. Mueller, Mario Chen, Le'Marus Alston, Marcus Hawley, Eunice Okumu, Natalie T. Eley, Tonya Stancil & Kathleen M. MacQueen. (2016) Concurrency and Other Sexual Risk Behaviors Among Black Young Adults in a Southeastern City. AIDS Education and Prevention 28:1, pages 59-76.
Crossref
Crossref
Alyssa R. Martin & Robert F. Siliciano. (2016) Progress Toward HIV Eradication: Case Reports, Current Efforts, and the Challenges Associated with Cure. Annual Review of Medicine 67:1, pages 215-228.
Crossref
Crossref
Maggie L Bobbin, John C Burnett & John J Rossi. (2015) RNA interference approaches for treatment of HIV-1 infection. Genome Medicine 7:1.
Crossref
Crossref
Ronald A Brooks, Raphael J Landovitz, Rotrease Regan, Sung-Jae Lee & Vincent C AllenJrJr. (2015) Perceptions of and intentions to adopt HIV pre-exposure prophylaxis among black men who have sex with men in Los Angeles. International Journal of STD & AIDS 26:14, pages 1040-1048.
Crossref
Crossref
Bonita Stanton. (2015) Teachers’ Patterns of Implementation of an Evidence-Based Intervention and Their Impact on Student Outcomes: Results from a Nationwide Dissemination over 24-Months Follow-Up. AIDS and Behavior 19:10, pages 1828-1840.
Crossref
Crossref
Kenneth S. Rosenthal, Joseph Sikon & Aaron Kuntz. (2015) Why Don’t We Have a Vaccine Against……….? Part 1. Viruses. Infectious Diseases in Clinical Practice 23:4, pages 202-210.
Crossref
Crossref
Paul Goepfert & Anju Bansal. (2014) Human Immunodeficiency Virus Vaccines. Infectious Disease Clinics of North America 28:4, pages 615-631.
Crossref
Crossref
Ted M. RossLara E. PereiraAmara LuckayJanet M. McNichollJ. Gerardo García-LermaWalid HeneineHermancia S. EugeneBrooke R. Pierce-PaulJining ZhangR. Michael HendryJames M. Smith. (2014) A Polyvalent Clade B Virus-Like Particle HIV Vaccine Combined with Partially Protective Oral Preexposure Prophylaxis Prevents Simian–Human Immunodeficiency Virus Infection in Macaques and Primes for Virus-Amplified Immunity. AIDS Research and Human Retroviruses 30:11, pages 1072-1081.
Crossref
Crossref
Tamsin J. Garrod, Tessa Gargett, Wenbo Yu, Lee Major, Christopher J. Burrell, Steven Wesselingh, Andreas Suhrbier, Branka Grubor-Bauk & Eric J. Gowans. (2014) Loss of long term protection with the inclusion of HIV pol to a DNA vaccine encoding gag. Virus Research 192, pages 25-33.
Crossref
Crossref
D. Lema, A. Garcia & J. B. De Sanctis. (2014) HIV Vaccines: A Brief Overview. Scandinavian Journal of Immunology 80:1, pages 1-11.
Crossref
Crossref
Chloe K. Slichter, David P. Friedrich, Rebecca J. Smith, Paula N. Walsh, Greg Mize, Julie L. Czartoski, M. Juliana McElrath & Nicole Frahm. (2014) Measuring inhibition of HIV replication by ex vivo CD8+ T cells. Journal of Immunological Methods 404, pages 71-80.
Crossref
Crossref
Lai-Xi Wang, Paolo Costantino, Yu Geng & Hong Zhang. 2014. HIV glycans in infection and immunity. HIV glycans in infection and immunity
143
176
.
Matthew G. Cottingham & Miles W. Carroll. (2013) Recombinant MVA vaccines: dispelling the myths. Vaccine 31:39, pages 4247-4251.
Crossref
Crossref
Sten H. Vermund, José A. Tique, Holly M. Cassell, Megan E. Pask, Philip J. Ciampa & Carolyn M. Audet. (2013) Translation of Biomedical Prevention Strategies for HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 63:Supplement 1, pages S12-S25.
Crossref
Crossref
Monica Vaccari, Brandon F. Keele, Steven E. Bosinger, Melvin N. Doster, Zhong-Min Ma, Justin Pollara, Anna Hryniewicz, Guido Ferrari, Yongjun Guan, Donald N. Forthal, David Venzon, Claudio Fenizia, Tia Morgan, David Montefiori, Jeffrey D. Lifson, Chris J. Miller, Guido Silvestri, Margherita Rosati, Barbara K. Felber, George N. Pavlakis, James Tartaglia & Genoveffa Franchini. (2013)
Protection Afforded by an HIV Vaccine Candidate in Macaques Depends on the Dose of SIV
mac251
at Challenge Exposure
. Journal of Virology 87:6, pages 3538-3548.
Crossref
Crossref
Ali AziziKerrie Nichol EdamuraGlenda LeungLucy Gisonni-LexLaurent Mallet. (2013) Short Communication: Evaluating the Level of Expressed HIV Type 1 gp120 and gag Proteins in the vCP1521 Vector by Two Immunoplaque Methods. AIDS Research and Human Retroviruses 29:2, pages 397-399.
Crossref
Crossref
Akinobu Kajikawa, Lin Zhang, Julie Long, Shila Nordone, Laura Stoeker, Alora LaVoy, Sara Bumgardner, Todd Klaenhammer & Gregg Dean. (2012) Construction and Immunological Evaluation of Dual Cell Surface Display of HIV-1 Gag and Salmonella enterica Serovar Typhimurium FliC in Lactobacillus acidophilus for Vaccine Delivery. Clinical and Vaccine Immunology 19:9, pages 1374-1381.
Crossref
Crossref
Jeffrey B. Ulmer, Peter W. Mason, Andrew Geall & Christian W. Mandl. (2012) RNA-based vaccines. Vaccine 30:30, pages 4414-4418.
Crossref
Crossref
Mark S. de Souza, Silvia Ratto-Kim, Weerawan Chuenarom, Alexandra Schuetz, Somsak Chantakulkij, Bessara Nuntapinit, Anais Valencia-Micolta, Doris Thelian, Sorachai Nitayaphan, Punnee Pitisuttithum, Robert M. Paris, Jaranit Kaewkungwal, Nelson L. Michael, Supachai Rerks-Ngarm, Bonnie Mathieson, Mary Marovich, Jeffrey R. Currier, Jerome H. Kim, Supachai Rerks-Ngarm, Supamit Chunsuttiwat, Nakorn Premsri, Chawetsan Namwat, Prayura Kunasol, Prasert Thongcharoen, Chirasak Khamboonruang, Punnee Pitisuttithum, Valai Bussaratid, Wirach Maek-a-nantawat, Jittima Dhitavat, Pravan Suntharasamai, Swangjai Pungpak, Siriwan Vanijanonta, Jaranit Kaewkunwal, Amnat Khamsiriwatchara, Pawinee Jarujareet, Sorachai Nitayaphan, Chirapa Easmila, Suchana Tabprasit, Viseth Ngauy, Robert Paris, Michael Benenson, Patricia Morgan, Weerawan Chuenarom, Arthur Brown, Mark de Souza, Rapee Trichavaroj, Alexandra Schuetz, Nusara Thaitawat, Bessara Nuntapinit, Kanyasiri Kongnonkok, Boot Keawboon, Yuwadee Phuang-Ngern, Susan Mason, Sanjay Gurunathan, Jim Tartaglia, John G. McNeil, Robin Harkness, Claude Meric, Lynn Baglyos, Raphaelle El Habib, Don Francis, Carter Lee, Elizabeth Adams, Jerome H. Kim, Merlin L. Robb, Nelson L. Michael, Mark Milazzo, Amy Bolen, Beryl Wessner, Silvia Ratto-Kim, Mary Marovich, Jeffrey Currier, Deborah L. Birx, Don Stablein, Terry Germanson, Len Dally, Jean-Louis Excler & Jeffrey Berenberg. (2012) The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope. The Journal of Immunology 188:10, pages 5166-5176.
Crossref
Crossref
Ma Luo, Christina A. Daniuk, Tamsir O. Diallo, Rupert E. Capina, Joshua Kimani, Charles Wachihi, Makubo Kimani, Thomas Bielawny, Trevor Peterson, Mark G. R. Mendoza, Sandra Kiazyk, T. Blake Ball & Francis A. Plummer. (2012) For Protection from HIV-1 Infection, More Might Not Be Better: a Systematic Analysis of HIV Gag Epitopes of Two Alleles Associated with Different Outcomes of HIV-1 Infection. Journal of Virology 86:2, pages 1166-1180.
Crossref
Crossref
Erica Andersen-Nissen, Antje Heit & M. Juliana McElrath. (2012) Profiling immunity to HIV vaccines with systems biology. Current Opinion in HIV and AIDS 7:1, pages 32-37.
Crossref
Crossref
Lai-Xi Wang. 2012. Glycobiology and Drug Design. Glycobiology and Drug Design
157
186
.
Holger Loessner, Astrid Schwantes, Matthias Hamdorf, Uliana Komor, Sara Leschner & Siegfried Weiss. 2012. Development of Novel Vaccines. Development of Novel Vaccines
87
124
.
Yoshio Fujita & Hiroaki Taguchi. (2011) Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles. Chemistry Central Journal 5:1.
Crossref
Crossref
Veronica Rainone, Gregor Dubois, Vladimir Temchura, Klaus Überla, Alberto Clivio, Manuela Nebuloni, Eleonora Lauri, Daria Trabattoni, Francisco Veas & Mario Clerici. (2011) CCL28 Induces Mucosal Homing of HIV-1-Specific IgA-Secreting Plasma Cells in Mice Immunized with HIV-1 Virus-Like Particles. PLoS ONE 6:10, pages e26979.
Crossref
Crossref
Marcos Pérez-Losada, David V. Jobes, Faruk Sinangil, Keith A. Crandall, Miguel Arenas, David Posada & Phillip W. Berman. (2011) Phylodynamics of HIV-1 from a Phase III AIDS Vaccine Trial in Bangkok, Thailand. PLoS ONE 6:3, pages e16902.
Crossref
Crossref